rxstat › Classes › Antithrombotic Agents
Antithrombotic Agents: shortage status in Canada
10 of the 25 antithrombotic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Nadroparin (Fraxiparine) Widespread shortage 7 of 8 reported products affected
Ticagrelor Widespread shortage 2 of 4 reported products affected · est. return Sep 25, 2026
Apixaban Partial shortage 1 of 10 reported products affected · est. return Jul 31, 2026
Bivalirudin (Angiomax) Partial shortage 1 of 3 reported products affected
Clopidogrel (Plavix) Partial shortage 4 of 18 reported products affected · est. return Nov 10, 2026
Dabigatran Etexilate (Pradaxa) Partial shortage 2 of 6 reported products affected
Edoxaban (Lixiana) Partial shortage 1 of 6 reported products affected
Rivaroxaban (Xarelto) Partial shortage 4 of 18 reported products affected · est. return Nov 30, 2026
Ticlopidine Partial shortage 1 of 1 reported products affected
Warfarin (Coumadin) Partial shortage 3 of 23 reported products affected · est. return Aug 7, 2026
Heparin Shortage anticipated 0 of 11 reported products affected
Tinzaparin (Innohep) Shortage anticipated 0 of 11 reported products affected
Abciximab (Reopro) Discontinued 0 of 1 reported products affected
Acenocoumarol (Sintrom) Discontinued 0 of 2 reported products affected
Acetylsalicylic Acid Dipyridamole (Aggrenox) Discontinued 0 of 2 reported products affected
Alteplase (Cathflo) No current shortage
Argatroban No current shortage
Dipyridamole (Persantine) No current shortage
Enoxaparin (Lovenox) No current shortage
Epoprostenol (Flolan) No current shortage
Eptifibatide (Integrilin) Discontinued 0 of 4 reported products affected
Heparin Dextrose No current shortage
Heparin Dibasic Citric Acid Dextrose No current shortage
Rivaroxaban (Xarelto) Discontinued 0 of 1 reported products affected
Water Alteplase (Activase Rt-Pa) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.